News Biotech CEOs confident, but public markets still shaky Survey shows biotech CEO sentiment still strong
News Eleven seals deal with Roche on eye drug pipeline Deal helps biotech to move on from phase 3 failures
Views & Analysis Will the UK ever produce a world-class biotech company? Kymab, F-star and Mission Therapeutics among crop of new UK biotechs.
News Zafgen ends development of Prader-Willi drug Share price plummets after biotech said drug is unsafe.
News George Freeman promoted, leaving Life Science minister role ... Life Science minister post set to be scrapped
News Amgen's Horizon buyout delivers Sjögren's disease win Amgen's anti-CD40L drug dazodalibep has shown efficacy in Sjögren's in a phase 3 trial, raising hopes for a disease-modifying drug for the disorder.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
